Apyx MedicalAPYX
Market Cap: $45M
About: Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Employees: 252
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
48,200% more call options, than puts
Call options by funds: $483K | Put options by funds: $1K
0.59% less ownership
Funds ownership: 37.77% [Q1] → 37.18% (-0.59%) [Q2]
3% less capital invested
Capital invested by funds: $17.8M [Q1] → $17.3M (-$535K) [Q2]
4% less funds holding
Funds holding: 50 [Q1] → 48 (-2) [Q2]
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Research analyst outlook
We haven’t received any recent analyst ratings for APYX.